Analyzing Allogene Therapeutics Inc (ALLO) After Recent Trading Activity

Allogene Therapeutics Inc’s recently made public that its CHIEF FINANCIAL OFFICER Parker Geoffrey M. acquired Company’s shares for reported $683.0 on Jan 30 ’24. In the deal valued at $3.60 per share,190 shares were bought. As a result of this transaction, Parker Geoffrey M. now holds 819,590 shares worth roughly $3.45 million. Then, MESSEMER DEBORAH […]

Investing in Allogene Therapeutics Inc (ALLO): What You Must Know

In a filing, Allogene Therapeutics Inc revealed its CHIEF FINANCIAL OFFICER Parker Geoffrey M. acquired Company’s shares for reported $683.0 on Jan 30 ’24. In the deal valued at $3.60 per share,190 shares were bought. As a result of this transaction, Parker Geoffrey M. now holds 819,590 shares worth roughly $3.6 million. Then, MESSEMER DEBORAH […]

Allogene Therapeutics Inc [ALLO] Investment Appeal on the Rise

NUE

Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $50317.0 on Dec 18. In the deal valued at $2.70 per share,18,640 shares were sold. As a result of this transaction, MESSEMER DEBORAH M. now holds 62,456 shares worth roughly $0.32 million. Then, Mayo Stephen sold 10,000 shares, […]

Short interest on ALLO sees a significant decrease on Jan 31, 2024

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics Inc shares valued at $50,317 were sold by MESSEMER DEBORAH M. on Dec 18. At $2.70 per share, MESSEMER DEBORAH M. sold 18,640 shares. The insider’s holdings dropped to 62,456 shares worth approximately $0.31 million […]